$AbCellera Biologics(ABCL)$We are encouraged that the next generation of treatments – such as oral antivirals – may soon be available as these can be manufactured and administered more efficiently. Lilly is talking with regulators to understand the potential need for additional therapies, like bebtelovimab, and will continue to do our part based on the available science and needs of society.
精彩评论